- Home
- PULM vs STAI Comparison
PULM vs STAI Comparison
Compare PULM & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- STAI
- Stock Information
- Founded
- PULM 2003
- STAI 2011
- Country
- PULM United States
- STAI United States
- Employees
- PULM N/A
- STAI N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- STAI
- Sector
- PULM Health Care
- STAI
- Exchange
- PULM Nasdaq
- STAI Nasdaq
- Market Cap
- PULM 28.3M
- STAI 24.7M
- IPO Year
- PULM N/A
- STAI N/A
- Fundamental
- Price
- PULM $8.90
- STAI $0.76
- Analyst Decision
- PULM
- STAI
- Analyst Count
- PULM 0
- STAI 0
- Target Price
- PULM N/A
- STAI N/A
- AVG Volume (30 Days)
- PULM 20.6K
- STAI 970.9K
- Earning Date
- PULM 05-15-2025
- STAI 01-01-0001
- Dividend Yield
- PULM N/A
- STAI N/A
- EPS Growth
- PULM N/A
- STAI N/A
- EPS
- PULM N/A
- STAI N/A
- Revenue
- PULM $1,921,000.00
- STAI $542,166.00
- Revenue This Year
- PULM N/A
- STAI N/A
- Revenue Next Year
- PULM $134.88
- STAI N/A
- P/E Ratio
- PULM N/A
- STAI N/A
- Revenue Growth
- PULM N/A
- STAI N/A
- 52 Week Low
- PULM $1.78
- STAI $0.70
- 52 Week High
- PULM $10.40
- STAI $9.07
- Technical
- Relative Strength Index (RSI)
- PULM 69.72
- STAI N/A
- Support Level
- PULM $7.94
- STAI N/A
- Resistance Level
- PULM $9.37
- STAI N/A
- Average True Range (ATR)
- PULM 0.66
- STAI 0.00
- MACD
- PULM 0.30
- STAI 0.00
- Stochastic Oscillator
- PULM 88.69
- STAI 0.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About STAI ScanTech AI Systems Inc. Common stock
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.